Investing in software engineering to advance Bioconductor for genomic research
Official title: Investing in Research Software Engineering for Expert Development and Dissemination of Bioconductor
Funded at Roswell Park Cancer Institute Corp · NIH-11415122 · Data updated 2026-11-12
A grant to support Lori Kern’s work developing and spreading Bioconductor software that scientists use for genetic and genomic research.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project start | September 3, 2025 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $168,448 |
| NIH project number | 5R50LM015262-02 |
| Project ID | NIH-11415122 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals whose care could eventually benefit from advanced genomic analyses and open-source bioinformatics tools.
✕Less likely to help
Patients not directly involved in genomic studies or those whose care does not rely on Bioconductor workflows may not experience immediate benefits.
What this research studies
This funding backs the career development of a key Bioconductor developer. It focuses on improving how Bioconductor curates, documents, and shares data and analysis tools so researchers can more easily reuse and trust genomic resources. The project emphasizes open, community-driven software engineering to expand global computational genomics capabilities. It includes enhancing data standards, FAIR4RS principles, and the dissemination of high‑quality genomic annotations and datasets. The work aims to speed the translation of genomic findings into insights that benefit patients.
Why it matters
Potential benefit: If successful, clinicians and researchers could access better, more reliable genomic tools and data to inform diagnosis and treatment.
How similar studies have gone: Similar open-source bioinformatics initiatives have shown sustained community use and impact when accompanied by robust documentation and governance.
Where this research is happening
-
Roswell Park Cancer Institute Corp
Buffalo, United States Active
Researchers
- Principal investigator: Kern, Lori — Roswell Park Cancer Institute Corp
- Study coordinator: Kern, Lori
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.